Urabe F, Muramoto K, Yanagisawa T, Fukuokaya W, et al. Changes in the treatment landscape of metastatic hormone-sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study. Int J Urol 2024 Jul 19. doi: 10.1111/iju.15546.
PMID: 39031448